Lixte Biotechnology Holdings Inc (LIXT)
2.89
+0.01
(+0.27%)
USD |
NASDAQ |
May 03, 16:00
2.89
0.00 (0.00%)
After-Hours: 20:00
Lixte Biotechnology Holdings Total Liabilities (Quarterly): 0.3139M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.3139M |
| September 30, 2023 | 0.3117M |
| June 30, 2023 | 0.4026M |
| March 31, 2023 | 0.25M |
| December 31, 2022 | 0.3958M |
| September 30, 2022 | 0.4083M |
| June 30, 2022 | 0.5315M |
| March 31, 2022 | 0.6446M |
| December 31, 2021 | 0.3029M |
| September 30, 2021 | 0.2587M |
| June 30, 2021 | 0.3763M |
| March 31, 2021 | 0.2424M |
| December 31, 2020 | 0.2165M |
| September 30, 2020 | 0.2215M |
| June 30, 2020 | 0.214M |
| March 31, 2020 | 0.2253M |
| December 31, 2019 | 0.2379M |
| September 30, 2019 | 0.3093M |
| June 30, 2019 | 0.223M |
| March 31, 2019 | 0.2448M |
| December 31, 2018 | 0.2109M |
| September 30, 2018 | 0.459M |
| June 30, 2018 | 0.3383M |
| March 31, 2018 | 0.2387M |
| December 31, 2017 | 0.373M |
| Date | Value |
|---|---|
| September 30, 2017 | 0.2562M |
| June 30, 2017 | 0.2418M |
| March 31, 2017 | 0.2545M |
| December 31, 2016 | 0.2187M |
| September 30, 2016 | 0.1956M |
| June 30, 2016 | 0.1396M |
| March 31, 2016 | 0.1926M |
| December 31, 2015 | 0.2856M |
| September 30, 2015 | 0.2222M |
| June 30, 2015 | 0.1982M |
| March 31, 2015 | 0.2542M |
| December 31, 2014 | 0.2734M |
| September 30, 2014 | 0.4023M |
| June 30, 2014 | 0.3272M |
| March 31, 2014 | 0.2842M |
| December 31, 2013 | 0.3218M |
| September 30, 2013 | 0.2935M |
| June 30, 2013 | 0.266M |
| March 31, 2013 | 0.2701M |
| December 31, 2012 | 0.2612M |
| September 30, 2012 | 0.2465M |
| June 30, 2012 | 0.3513M |
| March 31, 2012 | 0.4671M |
| December 31, 2011 | 0.3507M |
| September 30, 2011 | 0.3624M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.214M
Minimum
Jun 2020
0.6446M
Maximum
Mar 2022
0.3203M
Average
0.3029M
Median
Dec 2021
Total Liabilities (Quarterly) Benchmarks
| iBio Inc | 24.82M |
| PAVmed Inc | 57.14M |
| PDS Biotechnology Corp | 33.26M |
| Moleculin Biotech Inc | 12.14M |
| Syros Pharmaceuticals Inc | 151.51M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.309M |
| Shareholders Equity (Quarterly) | 3.995M |